Literature DB >> 18187099

Cutaneous Aspergillus ustus in a lung transplant recipient: emergence of a new opportunistic fungal pathogen.

Parsia A Vagefi1, A Benedict Cosimi, Leo C Ginns, Camille N Kotton.   

Abstract

Opportunistic fungal infections remain a significant complication in immunosuppressed patients, especially those having undergone solid-organ transplantation. We report a 39-year-old patient who represents the second case of cutaneous Aspergillus ustus infection in a solid-organ transplant recipient, and the first documented case after lung transplantation. The patient's cutaneous lower extremity aspergillosis responded to a combination of intravenous liposomal amphotericin B, caspofungin and topical terbinafine cream, with a concomitant reduction in immunosuppression. A. ustus is an emerging opportunistic fungal pathogen in transplant recipients.

Entities:  

Mesh:

Year:  2008        PMID: 18187099     DOI: 10.1016/j.healun.2007.09.020

Source DB:  PubMed          Journal:  J Heart Lung Transplant        ISSN: 1053-2498            Impact factor:   10.247


  5 in total

1.  Invasive Aspergillosis of the Hand Caused by Aspergillus ustus: a Case Report.

Authors:  Olushola Olorunnipa; Andrew Y Zhang; Catherine M Curtin
Journal:  Hand (N Y)       Date:  2009-06-30

2.  Skin and soft tissue infections in the transplant population.

Authors:  Camille Nelson Kotton
Journal:  Curr Infect Dis Rep       Date:  2008-09       Impact factor: 3.663

3.  New taxa in Aspergillus section Usti.

Authors:  R A Samson; J Varga; M Meijer; J C Frisvad
Journal:  Stud Mycol       Date:  2011-06-30       Impact factor: 16.097

4.  A genomics based discovery of secondary metabolite biosynthetic gene clusters in Aspergillus ustus.

Authors:  Borui Pi; Dongliang Yu; Fangwei Dai; Xiaoming Song; Congyi Zhu; Hongye Li; Yunsong Yu
Journal:  PLoS One       Date:  2015-02-23       Impact factor: 3.240

Review 5.  Emerging bacterial, fungal, and viral respiratory infections in transplantation.

Authors:  Shawn P E Nishi; Vincent G Valentine; Steve Duncan
Journal:  Infect Dis Clin North Am       Date:  2010-09       Impact factor: 5.982

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.